Monsanto’s Market-Dominating Weed Killers With Glyphosate Linked To Pregnancy Problems

Monsanto's Market-Dominating Weed Killers With Glyphosate Linked To Pregnancy Problems

A new study from the Children’s Environmental Health Network (“CEHN”) Healthy Kids Initiative testing 69 pregnant women, reveals  that exposure to the widely-used herbicide known as glyphosate accumulates in pregnant women and leads to unfavorable birth outcomes.

[Read more…]

Tiseme Zegeye Discusses Talcum Powder Links to Ovarian Cancer in New Lieff Cabraser Video

Tiseme Zegeye Discusses Talcum Powder Links to Ovarian Cancer in New Lieff Cabraser Video

Talcum powder has been used by women and girls for decades in what was thought to be a harmless method of absorbing moisture as a drying and anti-chafe agent. However, a U.S. jury verdict linking regular use of talcum powder to a women’s wrongful death from ovarian cancer highlights the potentially fatal risks from ongoing use of talcum powder products. [Read more…]

Study Indicates Prenatal Exposure to Industrial Pesticides Greatly Increases Risk of Autism

Study Indicates Prenatal Exposure to Industrial Pesticides Greatly Increases Risk of Autism

Increased food production in the U.S. often depends on the use of toxic agricultural pesticides, including chlorpyrifos, which a 2014 CHARGE study has linked to drastically increased risks of autism during prenatal development. [Read more…]

Talc Cancer Victim Awarded $70 Million by Missouri Jury

Talcum powder on black background

A Missouri state court jury awarded nearly $71 million dollars on Thursday to a woman claiming she developed ovarian cancer due to using Johnson & Johnson’s talc-containing personal hygiene products on her genitals for decades, who accused the company of not warning consumers about the products’ health risks in order to protect profitable brands. [Read more…]

FDA Classifies Transvaginal Mesh as High-Risk due to Serious Complications from Surgery

FDA Classifies Transvaginal Mesh As High Risk

The U.S. Food and Drug Administration (FDA) has reclassified the surgical mesh device utilized for transvaginal repair of pelvic organ prolapse (“POP”) and other conditions in women as a high-risk (class III) product. Previously, the agency classified the product as moderate-risk (class II). [Read more…]